Free Trial

Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Expands By 125.9%

Nihon Kohden logo with Medical background

Key Points

  • Nihon Kohden Corporation experienced a significant increase in short interest of 125.9% in August, rising from 2,700 to 6,100 shares.
  • The company reported last quarterly earnings on August 6, with an EPS of $0.01 and revenue of $346.24 million.
  • Nihon Kohden's stock is currently trading at $11.62, with a market cap of $1.99 billion and a fifty-two week range between $9.86 and $17.28.
  • MarketBeat previews the top five stocks to own by October 1st.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) was the target of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 6,100 shares, a growth of 125.9% from the August 15th total of 2,700 shares. Approximately 0.0% of the company's stock are short sold. Based on an average daily volume of 10,800 shares, the days-to-cover ratio is currently 0.6 days. Based on an average daily volume of 10,800 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.0% of the company's stock are short sold.

Nihon Kohden Stock Up 0.6%

NHNKY traded up $0.07 during trading on Friday, hitting $11.62. 3,749 shares of the company's stock were exchanged, compared to its average volume of 6,087. The business's 50 day moving average is $11.67 and its two-hundred day moving average is $12.50. The stock has a market cap of $1.99 billion, a P/E ratio of 21.51 and a beta of 0.40. Nihon Kohden has a fifty-two week low of $9.86 and a fifty-two week high of $17.28.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.01 EPS for the quarter. The firm had revenue of $346.24 million during the quarter. Nihon Kohden had a net margin of 5.77% and a return on equity of 6.74%.

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nihon Kohden Right Now?

Before you consider Nihon Kohden, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.

While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.